Clinical Trials Browser

Phase 3 × Hepatitis C, Chronic × daclatasvir × Clear all

NCT02771405 2026-04-13

FRI-STC

Phase 3 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Hepatitis C, Chronic